Regulatory Affairs Specialist II at Fractyl Health

Burlington, Massachusetts, United States

Fractyl Health Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Medical Devices, HealthcareIndustries

Requirements

  • Bachelor’s degree in Scientific, Engineering, Public Health, or a related field
  • RAPs Certification preferred
  • Minimum of 3 years of direct experience in Regulatory Affairs or a related field
  • Background in medical devices, biologics, or pharmaceutical industries (medical devices preferred)
  • Strong understanding of FDA and EU regulations and guidance documents
  • Knowledge of Quality System requirements such as QSR, ISO 13485, GxP
  • Solid technical writing skills with experience preparing regulatory documentation
  • Project management skills and the ability to manage timelines within a team environment
  • Experience with software-based and/or sterile medical devices desirable but not required
  • Experience with clinical trials desirable but not required
  • Demonstrated ability to work independently and as part of a cross-functional team
  • Strong organizational skills with attention to detail
  • Excellent verbal and written communication skills
  • Curious, proactive, and eager to learn within a dynamic, fast-paced environment
  • High degree of professionalism, integrity, and commitment to quality

Responsibilities

  • Support the development and implementation of regulatory submission strategies
  • Assist with the preparation and maintenance of US regulatory submissions, including IDEs, PMAs, and associated supplements and reports
  • Help achieve/maintain CE Marking including MDR applications, maintaining technical documentation, and associated compliance activities
  • Support review of project documentation such as risk management files, test reports, and validations for regulatory completeness
  • Assess Engineering Change Orders (ECOs) for potential regulatory impact
  • Collaborate with cross-functional teams to address questions and support responses during submission reviews
  • Assist in drafting or updating regulatory standard operating procedures (SOPs)
  • Support review of promotional materials for compliance with regulatory requirements
  • Contribute to clinical trial activities and documentation in line with good clinical practice (GCP) standards
  • Support internal and external audits and other quality system activities as needed
  • Perform all duties in compliance with applicable regulations, policies, and procedures, including timely documentation and training completion
  • Bring a collaborative, solution-oriented attitude to daily work and other responsibilities as assigned

Skills

Regulatory Submissions
IDE
PMA
CE Marking
MDR
GCP
SOPs
Engineering Change Orders
Risk Management
Audits
Promotional Materials Review
Technical Documentation

Fractyl Health

Therapies for Type 2 Diabetes treatment

About Fractyl Health

Fractyl focuses on creating therapies for Type 2 Diabetes (T2D) and obesity, targeting the root causes of these metabolic diseases. Their main product, Rejuva, is a gene therapy designed to enhance the function of islet cells in the pancreas, which are essential for blood sugar regulation. By improving these cells, Fractyl aims to help patients achieve long-term remission from T2D and obesity. Currently, Rejuva is in preclinical development and has received a CE mark for commercial availability in Europe, although it is still awaiting full FDA approval. Unlike many competitors, Fractyl's approach centers on addressing the underlying mechanisms of these diseases rather than just managing symptoms. The company's goal is to transform the treatment landscape for T2D and obesity, ultimately preventing and eliminating these conditions.

Lexington, KentuckyHeadquarters
2010Year Founded
$282.2MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Risks

Competition from established companies like Novo Nordisk poses a threat.
Regulatory challenges with FDA approval could delay Rejuva's market entry.
Market volatility may impact the success of Fractyl's IPO.

Differentiation

Fractyl Health focuses on minimally invasive therapies for chronic diseases.
Revita DMR rejuvenates the duodenum lining, improving patient health.
Rejuva platform targets pancreatic islet cells for long-term T2D remission.

Upsides

Growing demand for minimally invasive procedures boosts Fractyl's market potential.
European diabetes care market offers lucrative opportunities for Revita DMR.
Experienced leadership enhances Fractyl's commercial strategy and product launch readiness.

Land your dream remote job 3x faster with AI